Clinical Trial Update: A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to confirm the efficacy and safety of HS-10374 for moderate to severe plaque psoriasis is planned, with status NOT_YET_RECRUITING and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• HS-10374

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Psoriasis | Phase 3 | Status: NOT_YET_RECRUITING